Your account is not claimed yet. You can sign up with ORCID to claim your account.

Shoujiao Peng

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 13

Top Venues

The Journal of experimental medicine

International journal of molecular sciences

BioFactors (Oxford, England)

Food & function

Lanzhou University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Lanzhou University Sep 1o 2014

China

PHD :: State Key Laboratory of Applied Organic Chemistry and College of Chemistry and Chemical Engineering

Publications

Shoujiao Peng, Shaopeng Yu, Junmin Zhang, Jiange Zhang
6-Shogaol as a Novel Thioredoxin Reductase Inhibitor Induces Oxidative-Stress-Mediated Apoptosis in HeLa Cells. International journal of molecular sciences 24 (5) (2023)
Shoujiao Peng, Shaopeng Yu, Junmin Zhang, Jiange Zhang
6-Shogaol as a Novel Thioredoxin Reductase Inhibitor Induces Oxidative-Stress-Mediated Apoptosis in HeLa Cells. International journal of molecular sciences 24 (5) (2023)
Shoujiao Peng, Shaopeng Yu, Junmin Zhang, Jiange Zhang
6-Shogaol as a Novel Thioredoxin Reductase Inhibitor Induces Oxidative-Stress-Mediated Apoptosis in HeLa Cells. International journal of molecular sciences 24 (5) (2023)
Ji-Hak Jeong, Shangwei Zhong, Fuzhuo Li, Changhao Huang, Xueyan Chen, Qingqing Liu, Shoujiao Peng, HaJeung Park, You Mie Lee, Jasreman Dhillon, Jun-Li Luo
Tumor-derived OBP2A promotes prostate cancer castration resistance. The Journal of experimental medicine 220 (3) (2022)
Ji-Hak Jeong, Shangwei Zhong, Fuzhuo Li, Changhao Huang, Xueyan Chen, Qingqing Liu, Shoujiao Peng, HaJeung Park, You Mie Lee, Jasreman Dhillon, Jun-Li Luo
Tumor-derived OBP2A promotes prostate cancer castration resistance. The Journal of experimental medicine 220 (3) (2022)
Ji-Hak Jeong, Shangwei Zhong, Fuzhuo Li, Changhao Huang, Xueyan Chen, Qingqing Liu, Shoujiao Peng, HaJeung Park, You Mie Lee, Jasreman Dhillon, Jun-Li Luo
Tumor-derived OBP2A promotes prostate cancer castration resistance. The Journal of experimental medicine 220 (3) (2022)
Shangwei Zhong, Shoujiao Peng, Zihua Chen, Zhikang Chen, Jun-Li Luo
Choosing Kinase Inhibitors for Androgen Deprivation Therapy-Resistant Prostate Cancer. Pharmaceutics 14 (3) (2022)
Ji-Hak Jeong, Shangwei Zhong, Fuzhuo Li, Changhao Huang, Xueyan Chen, Qingqing Liu, Shoujiao Peng, HaJeung Park, You Mie Lee, Jasreman Dhillon, Jun-Li Luo
Tumor-derived OBP2A promotes prostate cancer castration resistance. The Journal of experimental medicine 220 (3) (2022)
Ji-Hak Jeong, Shangwei Zhong, Fuzhuo Li, Changhao Huang, Xueyan Chen, Qingqing Liu, Shoujiao Peng, HaJeung Park, You Mie Lee, Jasreman Dhillon, Jun-Li Luo
Tumor-derived OBP2A promotes prostate cancer castration resistance. The Journal of experimental medicine 220 (3) (2022)
Juan Yao, Shoujiao Peng, Jianqiang Xu, Jianguo Fang
Reversing ROS-mediated neurotoxicity by chlorogenic acid involves its direct antioxidant activity and activation of Nrf2-ARE signaling pathway. BioFactors (Oxford, England) 45 (4) (2019)
Shoujiao Peng, Yanan Hou, Juan Yao, Jianguo Fang
Neuroprotection of mangiferin against oxidative damage via arousing Nrf2 signaling pathway in PC12 cells. BioFactors (Oxford, England) 45 (3) (2019)
Liangwei Zhang, Shoujiao Peng, Jinyu Sun, Juan Yao, Jie Kang, Yuesong Hu, Jian-Guo Fang
A specific fluorescent probe reveals compromised activity of methionine sulfoxide reductases in Parkinson's disease. Chemical science 8 (4) (2017)
Shoujiao Peng, Yanan Hou, Juan Yao, Jian-Guo Fang
Activation of Nrf2-driven antioxidant enzymes by cardamonin confers neuroprotection of PC12 cells against oxidative damage. Food & function 8 (3) (2017)

Shoujiao Peng.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Shoujiao Peng